The DOI matches its Crossref record; 229 of the 233 references it cites were found in a registry or an index.
Cellular survival: a play in three Akts
Open accessAbstract
The programmed cell death that occurs as part of normal mammalian development was first observed nearly a century ago (Collin 1906). It has since been established that approximately half of all neurons in the neuroaxis and >99.9% of the total number of cells generated during the course of a human lifetime go on to die through a process of apoptosis (for review, see Datta and Greenberg 1998; Vaux and Korsmeyer 1999). The induction of developmental cell death is a highly regulated process and can be suppressed by a variety of extracellular stimuli. The purification in the 1950s of the nerve growth factor (NGF), which promotes the survival of sympathetic neurons, set the stage for the discovery that peptide trophic factors promote the survival of a wide variety of cell types in vitro and in vivo (Levi-Montalcini 1987). The profound biological consequences of growth factor (GF) suppression of apoptosis are exemplified by the critical role of target-derived neurotrophins in the survival of neurons and the maintenance of functional neuronal circuits. (Pettmann and Henderson 1998). Recently, the ability of trophic factors to promote survival have been attributed, at least in part, to the phosphatidylinositide 38-OH kinase (PI3K)/c-Akt kinase cascade. Several targets of the PI3K/c-Akt signaling pathway have been recently identified that may underlie the ability of this regulatory cascade to promote survival. These substrates include two components of the intrinsic cell death machinery, BAD and caspase 9, transcription factors of the forkhead family, and a kinase, IKK, that regulates the NF-kB transcription factor. This article reviews the mechanisms by which survival factors regulate the PI3K/c-Akt cascade, the evidence that activation of the PI3K/c-Akt pathway promotes cell survival, and the current spectrum of c-Akt targets and their roles in mediating c-Akt-dependent cell survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated PKB activity via amplification of PI3K and PKB genes, mutational loss of PTEN, or activation of oncogenic receptor tyrosine kinase is a common feature of many human cancers (1,4,43).”
From Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation (2004) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–229 of 229
Tang, D. G., Li, L., Chopra, D. P., & Porter, A. T. (1998) · PubMed · Cited by 110
Bad Can Act as a Key Regulator of T Cell Apoptosis and T Cell Development
Mok, C.-L., Gil‐Gómez, G., Williams, O., Coles, M. C., Taga, S., Tolaini, M., Norton, T., Kioussis, D., & Brady, H. J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.575 · Cited by 105
Goswami, R., Lacson, R. C., Yang, E., Sam, R., & Unterman, T. G. (1994) · Endocrinology · doi:10.1210/endo.134.2.7507835 · Cited by 103
Augmentation of naive, Th1 and Th2 effector CD4 Responses by IL-6, IL-1 and TNF
Joseph, S. B., Miner, K. T., & Croft, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01 · Cited by 100
Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.
Altomare, D., Guo, K., Cheng, J., Sonoda, G., Walsh, K., & Testa (1995) · PubMed · Cited by 98
Dickens, M., Svitek, C. A., Culbert, A. A., O’Brien, R. M., & Tavaré, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20144 · Cited by 95
Dong, L., Zhang, R.-B., Langlais, P. R., He, H., Clark, M. C., Zhu, L. X., & Liu, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8117 · Cited by 94
Unterman, T. G., Fareeduddin, A., Harris, M. A., Goswami, R., Porcella, A., Costa, R. H., & Lacson, R. C. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2401 · Cited by 90
Nobes, C. D., & Tolkovsky, A. M. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01069.x · Cited by 88
Anti-apoptotic function of Rac in hematopoietic cells
Nishida, K., Kaziro, Y., & Satoh, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202301 · Cited by 87
The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
Sublett, J. E., Jeon, I., & Shapiro, D. N. (1995) · PubMed · Cited by 76
Co-stimulation-dependent activation of a JNK-kinase in T lymphocytes
Avraham, A., Jung, S., Samuels, Y., Seger, R., & Ben‐Neriah, Y. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199808)28:08 · Cited by 71
The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis
Rohn, J. L., Hueber, A., McCarthy, N. J., Lyon, D., Navarro, P., Burgering, B. M. T., & Evan, G. I. (1998) · Oncogene · doi:10.1038/sj.onc.1202393 · Cited by 69
Andjelković, M., Suidan, H. S., Meier, R., Frech, M., Alessi, D. R., & Hemmings, B. A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510195.x · Cited by 62
Sable, C. L., Filippa, N., Filloux, C., Hemmings, B. A., & OBBERGHEN, E. V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29600 · Cited by 59
Specific TrkA survival signals interfere with different apoptotic pathways
Ulrich, E., Düwel, A., Kauffmann-Zeh, A., Gilbert, C., Lyon, D., Rudkin, B. B., Evan, G. I., & Martı́n-Zanca, D. (1998) · Oncogene · doi:10.1038/sj.onc.1201842 · Cited by 58
Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma
Davis, R. J., Bennicelli, J. L., Macina, R. A., Nycum, L. M., Biegel, J. A., & Barr, F. G. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.12.2355 · Cited by 58
Sung, S. J., Walters, J. A., Hudson, J. M., & Gimble, J. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.2047 · Cited by 53
Meier, P., & Evan, G. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81760-2 · Cited by 53
Kaipia, A. J., Hsu, S. Y., & Hsueh, A. J. W. (1997) · Endocrinology · doi:10.1210/endo.138.12.5588 · Cited by 52
Intracellular Signaling Pathways Activated by Neurotrophic Factors
Segal, R. A. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.19.1.463 · Cited by 43
Recognition and interaction of small rings with the ricin A-chain binding site
Yan, X., Day, P., Hollis, T., Monzingo, A. F., Schelp, E., Robertus, J. D., Milne, G. W. A., & Wang, S. (1998) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(19980401)31:1 · Cited by 35
Avian cellular homolog of the qin oncogene.
Chang, H. W., Li, J., Kretzschmar, D., & Vogt, P. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.447 · Cited by 28
Multiple proteins bind the insulin response element in the human IGFBP-1 promoter
Powell, D. R., Allander, S. V., Scheimann, A. O., Wasserman, R. M., Durham, S. K., & Suwanichkul, A. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00034-8 · Cited by 27
Zhang, X., & Vik, T. A. (1997) · Leukemia Research · doi:10.1016/s0145-2126(97)00055-6 · Cited by 18
Molecular Mechanisms of Neuronal Survival and Apoptosis
Datta, S. R., & Greenberg, M. E. (1998) · Elsevier eBooks · doi:10.1016/b978-012312411-1/50010-x · Cited by 16
Self-citationKaipia, A. (1997) · Endocrinology · doi:10.1210/en.138.12.5497 · Cited by 14
Coffer, P. J., Schweizer, R. C., Dubois, G. R., et al. (1998) · Blood · doi:10.1182/blood.v91.7.2547.2547_2547_2557 · Cited by 11
Berra, E., Díaz-Meco, M. T., & Moscat, J. (1998) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80788-8 · Cited by 10
Flagged first, then by citations
4 of the 233 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Bonni, A., A. Brunet, A.E. West, S.R. Datta, and M.E. Greenberg. 1999. The ras-MAPK signaling pathway promotes cell sur- vival via a dual transcription-dependent and transcription- independent mechanism. Science (in press).
- Cheng, J.Q., B. Ruggeri, W.M. Klein, G. Sonoda, D.A. Altomare, D.K. Watson, and J.R. Testa. 1996. Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 ex- pression and tunorigeneicity by antisense RNA. Proc. Natl. Acad. Sci. 93: 3636-3641.
- Kitamura, T., W. Ogawa, H. Sakaue, Y. Hino, S. Kuroda, M. Takata, M. Matsumoto, T. Maeda, H. Konishi, U. Kikkawa et al. 1998a. Requirement for activation of the serine-threo- nine kinase Akt (PKB) in insulin stimulation of protein syn- thesis but not of glucose transport. Mol. Cell. Biol. 18: 3708- 3717.
- Staal, S.P. 1987. Molecular cloning of the akt oncogene and its human homologs Akt1 and Akt2: Amplification of Akt1 in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. 84: 5034-5037.
Cited by
Sorted by citations
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Metadata
- Authors
- Datta, S. R., Brunet, A., & Greenberg, M. E.
- Affiliations
- Boston Children's Hospital (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-11-15
- Volume
- 13
- Issue
- 22
- Pages
- 2905-2927
- ISSN
- 0890-9369 (ISSN-L)
- OpenAlex
- W2147114673
- Cited by
- 4,216
- References
- 233
- Citations by year
- 2026: 27 · 2025: 36 · 2024: 45 · 2023: 47 · 2022: 60 · 2021: 68 · 2020: 87 · 2019: 86 · 2018: 81 · 2017: 94 · 2016: 90 · 2015: 140 · 2014: 136 · 2013: 149 · 2012: 150
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bentham-Moxon Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- cell survival, apoptosis, PI3K/Akt signaling, neurotrophins, trophic factors, developmental cell death, Bad, caspase-9, forkhead transcription factor, IκB kinase, NF-kB, neuronal survival, growth factor signaling
- MeSH terms
- Animals, Carrier Proteins, Cell Survival, Cell Transformation, Neoplastic, Humans, Phosphatidylinositols, Phosphorylation, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Substrate Specificity, Transcription Factors, Signal Transduction, NF-kappa B, Sequence Alignment, Apoptosis, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Phosphatidylinositol 3-Kinases, Protein Isoforms, Caspases, Glycogen Synthase Kinase 3, bcl-Associated Death Protein, Proto-Oncogene Proteins c-akt, Mice, Rats, I-kappa B Kinase, Caspase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review